Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Fink

Showing results (11-20 of 93) with videos related to

Pageof 10
Sort By:
European Journal of Pain (London, England)|April 14, 2011
Vector-mediated release of GABA attenuates pain-related behaviors and reduces Na(V)1.7 in DRG neuronsMunmun Chattopadhyay, Marina Mata, David J Fink
Behavioural Brain Research|September 2, 2008
Transgene-mediated enkephalin expression attenuates signs of naloxone-precipitated morphine withdrawal in rats with neuropathic painShuanglin Hao, Jian Hu, David J Fink
Experimental Neurology|November 5, 2003
Development of HSV-mediated gene transfer for the treatment of chronic painMarina Mata, Joseph Glorioso, David J Fink
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 7, 2010
Prevention of diabetic neuropathy by regulatable expression of HSV-mediated erythropoietinZetang Wu, Marina Mata, David J Fink
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 27, 2008
Continuous delta-opioid receptor activation reduces neuronal voltage-gated sodium channel (NaV1.7) levels through activation of protein kinase C in painful diabetic neuropathyMunmun Chattopadhyay, Marina Mata, David J Fink
Current Gene Therapy|March 14, 2008
Applications of gene therapy to the treatment of chronic painMarina Mata, Shuanglin Hao, David J Fink
Neuroscience Letters|May 9, 2012
Targeted drug delivery to the peripheral nervous system using gene therapyDarren Wolfe, Marina Mata, David J Fink
Neuroscience Letters|April 12, 2008
Gene therapy directed at the neuroimmune component of chronic pain with particular attention to the role of TNF alphaMarina Mata, Shuanglin Hao, David J Fink
Expert Opinion on Biological Therapy|April 14, 2006
Gene therapy for the treatment of sensory neuropathyMarina Mata, Munmun Chattopadhyay, David J Fink
Experimental Neurology|November 5, 2003
Therapeutic gene transfer with herpes-based vectors: studies in Parkinson's disease and motor nerve regenerationDavid J Fink, Joseph Glorioso, Marina Mata
Pageof 10

Showing results (11-20 of 93) with videos related to

Sort By:
Pageof 10
European Journal of Pain (London, England)|April 14, 2011
Vector-mediated release of GABA attenuates pain-related behaviors and reduces Na(V)1.7 in DRG neuronsMunmun Chattopadhyay, Marina Mata, David J Fink
Behavioural Brain Research|September 2, 2008
Transgene-mediated enkephalin expression attenuates signs of naloxone-precipitated morphine withdrawal in rats with neuropathic painShuanglin Hao, Jian Hu, David J Fink
Experimental Neurology|November 5, 2003
Development of HSV-mediated gene transfer for the treatment of chronic painMarina Mata, Joseph Glorioso, David J Fink
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 7, 2010
Prevention of diabetic neuropathy by regulatable expression of HSV-mediated erythropoietinZetang Wu, Marina Mata, David J Fink
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 27, 2008
Continuous delta-opioid receptor activation reduces neuronal voltage-gated sodium channel (NaV1.7) levels through activation of protein kinase C in painful diabetic neuropathyMunmun Chattopadhyay, Marina Mata, David J Fink
Current Gene Therapy|March 14, 2008
Applications of gene therapy to the treatment of chronic painMarina Mata, Shuanglin Hao, David J Fink
Neuroscience Letters|May 9, 2012
Targeted drug delivery to the peripheral nervous system using gene therapyDarren Wolfe, Marina Mata, David J Fink
Neuroscience Letters|April 12, 2008
Gene therapy directed at the neuroimmune component of chronic pain with particular attention to the role of TNF alphaMarina Mata, Shuanglin Hao, David J Fink
Expert Opinion on Biological Therapy|April 14, 2006
Gene therapy for the treatment of sensory neuropathyMarina Mata, Munmun Chattopadhyay, David J Fink
Experimental Neurology|November 5, 2003
Therapeutic gene transfer with herpes-based vectors: studies in Parkinson's disease and motor nerve regenerationDavid J Fink, Joseph Glorioso, Marina Mata
Pageof 10